On a gloomy Saturday afternoon in Everett, at the corner of 102nd Street and 19th Ave. in front of Costco, firefighters ...

SMART-101 is under clinical development by Smart Immune and currently in Phase II for Refractory Acute Myeloid Leukemia.

Firefighters were on the scene at the Costco in Everett on Saturday, but there were no flames to put out. They were there ...

Players, coaches, and families gathered in North Charleston Saturday for a benefit game in honor of Oceanside basketball ...

After overcoming a life-threatening superbug, Ben "Verse" Mount now faces a diagnosis of acute monoblastic leukemia and has ...

Brian Martell, far left, pictured in 2019 at the Juvenile Diabetes Research Foundation One Hope Ball at the Albany Marriott, ...

The Boston Celtics do a lot of great work in their community, as does their star forward Jayson Tatum. And the St. Louis ...

Practice-changing studies in both frontline CLL and relapsed/refractory disease, presented at ASH 2024, are discussed by Dr Jennifer Woyach.

Shares of Curis jumped after the company released what it assessed as positive data from a study of its in-development treatment for leukemia. The stock was up 33%, to $4.07, in midday trading ...

Highlights in chronic myeloid leukemia from ASH 2024 include data on efficacy of asciminib over TKIs, benefit from the third-generation TKI olverembatinib, and importance of molecular monitoring.

University of Minnesota Duluth (UMD) men's hockey senior Will Francis shared on Thursday that his leukemia has relapsed.